Search results for "MESENCHYMAL STEM CELLS"

showing 10 items of 213 documents

Menstruation: science and society

2020

© 2020 The Authors Women's health concerns are generally underrepresented in basic and translational research, but reproductive health in particular has been hampered by a lack of understanding of basic uterine and menstrual physiology. Menstrual health is an integral part of overall health because between menarche and menopause, most women menstruate. Yet for tens of millions of women around the world, menstruation regularly and often catastrophically disrupts their physical, mental, and social well-being. Enhancing our understanding of the underlying phenomena involved in menstruation, abnormal uterine bleeding, and other menstruation-related disorders will move us closer to the goal of p…

GerontologyBiomedical ResearchEndometriosisHealth literacyTranslational researchContext (language use)Global HealthEducationMenstruation03 medical and health sciencesEndometrium0302 clinical medicineTerminology as TopicMedicineHumansRegeneration030212 general & internal medicineMenstrual Hygiene ProductsDeveloping CountriesMenstruation DisturbancesReproductive health030219 obstetrics & reproductive medicineLeiomyomaTissue Engineeringbusiness.industryMicrobiotaStem CellsUterusTranslational medicineObstetrics and GynecologyNational Institute of Child Health and Human Development (U.S.)Mesenchymal Stem CellsCongresses as TopicMicrofluidic Analytical Techniquesmedicine.diseaseBiological EvolutionUnited StatesHealth LiteracyMenstruationMenopauseAttitudeUterine NeoplasmsMenarcheWomen's HealthFemaleUterine HemorrhagebusinessAdenomyosis
researchProduct

Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adul…

2010

Mesenchymal stem cells (MSC) are uniquely capable of crossing germinative layers borders (i.e. are able to differentiate towards ectoderm-, mesoderm- and endoderm-derived cytotypes) and are viewed as promising cells for regenerative medicine approaches in several diseases. Type I diabetes therapy should potentially benefit from such differentiated cells: the search for alternatives to organ/islet transplantation strategies via stem cells differentiation is an ongoing task, significant goals having been achieved in most experimental settings (e.g. insulin production and euglycaemia restoration), though caution is still needed to ensure safe and durable effects in vivo. MSC are obtainable in …

Graft RejectionCancer ResearchCellular differentiationCell Culture TechniquesClinical uses of mesenchymal stem cellsBiologyMesenchymal Stem Cell TransplantationRegenerative medicineUmbilical CordImmunomodulationMesenchymal stem cells Umbilical cord Wharton’s jelly Type 1 diabetes Beta cells Differentiation markers Pancreas development Inflammation Immune modulation HypoimmunogenicityInsulin-Secreting CellsWharton's jellyAnimalsHumansRegenerationEmbryonic Stem CellsSettore BIO/16 - Anatomia UmanaRegeneration (biology)Mesenchymal stem cellCell DifferentiationMesenchymal Stem CellsCell BiologyAntigens DifferentiationTransplantationAdult Stem CellsDiabetes Mellitus Type 1Adipose TissueImmunologyCancer researchCord Blood Stem Cell TransplantationStem cellStem Cell Reviews and Reports
researchProduct

Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation

2015

In the last decade there has been a rapid expansion in clinical trials using mesenchymal stromal cells (MSCs) from a variety of tissues. However, despite similarities in morphology, immunophenotype, and differentiation behavior in vitro, MSCs sourced from distinct tissues do not necessarily have equivalent biological properties. We performed a genome-wide methylation, transcription, and in vivo evaluation of MSCs from human bone marrow (BM), white adipose tissue, umbilical cord, and skin cultured in humanized media. Surprisingly, only BM-derived MSCs spontaneously formed a BM cavity through a vascularized cartilage intermediate in vivo that was progressively replaced by hematopoietic tissue…

Hematopoiesis and Stem CellsCellular differentiationBlotting WesternImmunologyCD34Bone Marrow CellsBiologyBiochemistryEpigenesis GeneticOsteogenesismedicineHumansCell LineageStem Cell NichefungiMesenchymal stem cellHematopoietic Tissuefood and beveragesCell DifferentiationMesenchymal Stem CellsCell BiologyHematologyAnatomyFlow CytometryHematopoietic Stem CellsCell biologyTransplantationmedicine.anatomical_structureBone marrowStem cellChondrogenesisHoming (hematopoietic)Blood
researchProduct

Recent Advances in Derivation of Functional Hepatocytes from Placental Stem Cells

2013

Abstract: End-stage liver diseases are one of the leading causes of death in the world. Often orthotopic liver transplantation represents the final therapeutic choice. The limits of this approach are the scarcity of donor livers available, and the many side effects related to the administration of immune suppressants to the patients. Cellular therapy for liver diseases is increasingly being viewed as a promising strategy to provide hepatocytes to replenish the parenchymal cells of the organ. This technique suffers of some important limitations, such as the difficulty in isolating sufficient cell numbers (e.g. when adult or foetal hepatocytes are used for transplantation), the limited viabil…

Hepatocyte differentiationMesenchymal stem cells Wharton’s jelly amniotic fluid amniotic membrane immune modulation umbilical cord hepatocyte differentiation functional assays inflammation fibrosis regenerative medicine tissue repair.Settore BIO/16 - Anatomia UmanaMesenchymal stem cellBiologyPlacenta cord bankingRegenerative medicineCell therapySettore MED/38 - Pediatria Generale E Specialisticamedicine.anatomical_structureDevelopmental NeuroscienceImmunologyCancer researchmedicineBone marrowStem cellDevelopmental BiologyAdult stem cellThe Open Tissue Engineering and Regenerative Medicine Journal
researchProduct

Human Wharton's jelly-derived mesenchymal stem cells express several immunomodulatory molecules both in their naïve state and hepatocyte-like differe…

2011

Wharton’s jelly (WJ), the main constituent of umbilical cord, is a reliable source of mesenchymal stem cells (MSC). WJ-MSC show unique ability in crossing lineage borders. As other extraembryonic mesenchymal populations (placenta and amnionderived cells), WJ-MSC express several immunomodulatory molecules, essential during the initial phases of human development. Indeed, our recent work pointed out the expression of non-classical HLA molecules as HLA-G in such cells, together with a favorable combination of B7 costimulators. Very few data in literature suggest that some of the immune features of the naïve cells are maintained after performing differentiation. The aim of this work was extendi…

Hepatocyte differentiationSettore BIO/16 - Anatomia UmanaImmunogenicityMesenchymal stem cellImmune regulationObstetrics and GynecologyClinical uses of mesenchymal stem cellsBiologyUmbilical cordCell biologymedicine.anatomical_structureReproductive MedicineHepatocyteImmunologyWharton's jellymedicineWharton's jelly mesenchymal stem cells umbilical cord hepatocyte differentiation markers immunogenicity immune regulationDevelopmental BiologyPlacenta
researchProduct

Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of n…

2008

The presence of multipotent cells in several adult and embryo-related tissues opened new paths for their use in regenerative medicine. Extraembryonic tissues such as umbilical cord are considered a promising source of stem cells, potentially useful in therapy. The characterization of cells from the umbilical cord matrix (Wharton''s Jelly) and amniotic membrane revealed the presence of a population of mesenchymal-like cells, sharing a set of core-markers expressed by "mesenchymal stem cells". Several reports enlightened the differentiation capabilities of these cells, even if at times the lack of an extensive characterization of surface markers and immune co-stimulators expression revealed h…

HistologyCell Culture TechniquesClinical uses of mesenchymal stem cellsCell SeparationBiologyUmbilical CordHLA AntigensHumansAmnionMolecular BiologyCell ProliferationStem cell transplantation for articular cartilage repairHLA-G AntigensSettore BIO/16 - Anatomia UmanaMultipotent Stem CellsHistocompatibility Antigens Class IMesenchymal stem cellCell DifferentiationMesenchymal Stem CellsAmniotic stem cellsCell BiologyTelomereCord liningCell biologyMedical Laboratory TechnologyMesenchymal stem cells Umbilical cord matrix Differentiation protocols Tolerogenic properties Self-renewal markersAmniotic epithelial cellsImmunologyStem cellOctamer Transcription Factor-3BiomarkersAdult stem cellHistochemistry and Cell Biology
researchProduct

Gene expression of stem cells at different stages of ontological human development.

2013

Abstract Objectives To compare multipotent mesenchymal stem cells (MSCs) obtained from chorionic villi (CV), amniotic fluid (AF) and placenta, with regard to their phenotype and gene expression, in order to understand if MSCs derived from different extra-embryonic tissues, at different stages of human ontological development, present distinct stemness characteristics. Study design MSCs obtained from 30 samples of CV, 30 of AF and 10 placentas (obtained from elective caesarean sections) were compared. MSCs at second confluence cultures were characterized by immunophenotypic analysis with flow cytometry using FACS CANTO II. The expression of the genes Oct-4 (Octamer-binding transcription fact…

Homeobox protein NANOGAdultPAX6 Transcription FactorKruppel-Like Transcription FactorsBiologyFetal DevelopmentYoung AdultMesenchymal stem cells; Extra-embryonic tissues; Gene expressionPregnancyGene expressionHumansPaired Box Transcription FactorsCD90Eye ProteinsMesenchymal stem cellHomeodomain ProteinsExtra-embryonic tissueSOXB1 Transcription FactorsMesenchymal stem cellObstetrics and GynecologyGene Expression Regulation DevelopmentalMesenchymal Stem CellsNanog Homeobox ProteinMiddle AgedAmniotic FluidMolecular biologyRepressor ProteinsHaematopoiesisSettore MED/18 - Chirurgia GeneraleReal-time polymerase chain reactionReproductive Medicineembryonic structuresFemaleRNA extractionGene expressionStem cellChorionic VilliOctamer Transcription Factor-3European journal of obstetrics, gynecology, and reproductive biology
researchProduct

Designed biodegradable hydrogel structures prepared by stereolithography using poly(ethylene glycol)/poly(D,L-lactide)-based resins

2010

Designed three-dimensional biodegradable poly(ethylene glycol)/poly(D,L-lactide) hydrogel structures were prepared for the first time by stereolithography at high resolutions. A photo-polymerisable aqueous resin comprising PDLLA-PEG-PDLLA-based macromer, visible light photo-initiator, dye and inhibitor in DMSO/water was used to build the structures. Porous and non-porous hydrogels with well-defined architectures and good mechanical properties were prepared. Porous hydrogel structures with a gyroid pore network architecture showed narrow pore size distributions, excellent pore interconnectivity and good mechanical properties. The structures showed good cell seeding characteristics, and human…

IR-80283Materials scienceStereolithographyPolyestersPharmaceutical ScienceDesigned porous structuresSCAFFOLDSHydrogel Polyethylene Glycol Dimethacrylatelaw.inventionPolyethylene GlycolsMacromer photo-polymerisationCONSTRUCTSchemistry.chemical_compoundMETIS-272859lawPolymer chemistryGLYCOL)Cell Adhesionmacromer photopolymerisationHumansTissue engineeringPorosityStereolithographyAqueous solutiontechnology industry and agricultureMesenchymal Stem CellsMacromonomerResins SyntheticPhotopolymerBiodegradation EnvironmentalchemistryChemical engineeringBiodegradable hydrogelsSelf-healing hydrogelsCELLS090301 BiomaterialsEthylene glycolGyroid
researchProduct

Immune-related molecole are espresse by both naive and differentiated Wharton’s jelly mesenchymal stem cells: a new avenue for cellular therapy

2012

Immune-related molecole Wharton’s jelly mesenchymal stem cells cellular therapy.Settore BIO/16 - Anatomia Umana
researchProduct

Induced Pluripotent Mesenchymal Stromal Cell Clones Retain Donor-derived Differences in DNA Methylation Profiles

2012

Reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is an epigenetic phenomenon. It has been suggested that iPSC retain some tissue-specific memory whereas little is known about interindividual epigenetic variation. We have reprogrammed mesenchymal stromal cells from human bone marrow (iP-MSC) and compared their DNA methylation profiles with initial MSC and embryonic stem cells (ESCs) using high-density DNA methylation arrays covering more than 450,000 CpG sites. Overall, DNA methylation patterns of iP-MSC and ESC were similar whereas some CpG sites revealed highly significant differences, which were not related to parental MSC. Furthermore, hypermethylation in iP-MSC…

Induced Pluripotent Stem CellsBiologyDrug DiscoveryGeneticsHumansEpigeneticsCancer epigeneticsInduced pluripotent stem cellMolecular BiologyPharmacologyMesenchymal Stromal CellsReverse Transcriptase Polymerase Chain ReactionMesenchymal Stem CellsMethylationDNA MethylationFlow CytometryMolecular biologyEmbryonic stem cellImmunohistochemistryClone CellsCpG siteDNA methylationMolecular MedicineOriginal ArticleCpG IslandsReprogrammingMolecular Therapy
researchProduct